The sirens' songs of confirmatory sepsis trials: Selection bias and sampling error

被引：111

作者：

Natanson, C ^{[1
]}

Esposito, CJ ^{[1
]}

Banks, SM ^{[1
]}

机构：

[1] NIH, Warren G Magnuson Clin Ctr, Dept Crit Care Med, Bethesda, MD 20892 USA

来源：

CRITICAL CARE MEDICINE | 1998年 / 26卷 / 12期

关键词：

sepsis; clinical trials; anti-inflammatory agents; infection; Gram-negative;

D O I：

10.1097/00003246-199812000-00001

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：1927 / 1931

页数：5

共 23 条

[1] EFFICACY AND SAFETY OF MONOCLONAL-ANTIBODY TO HUMAN TUMOR-NECROSIS-FACTOR-ALPHA IN PATIENTS WITH SEPSIS SYNDROME - A RANDOMIZED, CONTROLLED, DOUBLE-BLIND, MULTICENTER CLINICAL-TRIAL
ABRAHAM, E
WUNDERINK, R
SILVERMAN, H
PERL, TM
NASRAWAY, S
LEVY, H
BONE, R
WENZEL, RP
BALK, R
ALLRED, R
PENNINGTON, JE
WHERRY, JC
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (12): : 934 - 941
[2] Abraham E, 1998, LANCET, V351, P929
[3] p55 tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock - A randomized controlled multicenter trial
Abraham, E
Glauser, MP
Butler, T
Garbino, J
Gelmont, D
Laterre, PF
Kudsk, K
Bruining, HA
Otto, C
Tobin, E
Zwingelstein, C
Lesslauer, W
Leighton, A
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (19): : 1531 - 1538
[4] ABRAHAM E, 1998, INT C CHIC AM THOR S
[5] The effects of ibuprofen on the physiology and survival of patients with sepsis
Bernard, GR
Wheeler, AP
Russell, JA
Schein, R
Summer, WR
Steinberg, KP
Fulkerson, WJ
Wright, PE
Christman, BW
Dupont, WD
Higgins, SB
Swindell, BB
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (13) : 912 - 918
[6] PROSTACYCLIN AND THROMBOXANE-A2 FORMATION IS INCREASED IN HUMAN SEPSIS SYNDROME - EFFECTS OF CYCLOOXYGENASE INHIBITION
BERNARD, GR
REINES, HD
HALUSHKA, PV
HIGGINS, SB
METZ, CA
SWINDELL, BB
WRIGHT, PE
WATTS, FL
VRBANAC, JJ
[J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (05): : 1095 - 1101
[7] INTERSEPT: An international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis
Cohen, J
Carlet, J
[J]. CRITICAL CARE MEDICINE, 1996, 24 (09) : 1431 - 1440
[8] CDP571, A HUMANIZED ANTIBODY TO HUMAN TUMOR-NECROSIS-FACTOR-ALPHA - SAFETY, PHARMACOKINETICS, IMMUNE-RESPONSE, AND INFLUENCE OF THE ANTIBODY ON CYTOKINE CONCENTRATIONS IN PATIENTS WITH SEPTIC SHOCK
DHAINAUT, JFA
VINCENT, JL
RICHARD, C
LEJEUNE, P
MARTIN, C
FIEROBE, L
STEPHENS, S
NEY, UM
SOPWITH, M
MERCAT, A
EDOUARD, A
FRIEDMAN, G
MARIN, N
SCHLEMMER, B
LEPAPE, A
NOVAK, C
[J]. CRITICAL CARE MEDICINE, 1995, 23 (09) : 1461 - 1469
[9] PLATELET-ACTIVATING-FACTOR RECEPTOR ANTAGONIST BN-52021 IN THE TREATMENT OF SEVERE SEPSIS - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER CLINICAL-TRIAL
DHAINAUT, JFA
TENAILLON, A
LETULZO, Y
SCHLEMMER, B
SOLET, JP
WOLFF, M
HOLZAPFEL, L
ZENI, F
DREYFUSS, D
MIRA, JP
DEVATHAIRE, F
GUINOT, P
[J]. CRITICAL CARE MEDICINE, 1994, 22 (11) : 1720 - 1728
[10] Confirmatory platelet-activating factor receptor antagonist trial in patients with severe Gram-negative bacterial sepsis: A phase III, randomized, double-blind, placebo-controlled, multicenter trial
Dhainaut, JFA
Tenaillon, A
Hemmer, M
Damas, P
Le Tulzo, Y
Radermacher, P
Schaller, MD
Sollet, JP
Wolff, M
Holzapfel, L
Zeni, F
Vedrinne, JM
de Vathaire, F
Gourlay, ML
Guinot, P
Mira, JP
Holzapfel, L
Demingeon, G
Piralla, B
Zeni, F
Bertrand, JC
Motin, J
Vedrinne, JM
Dreyfuss, D
Coste, F
Mier, L
Faller, JP
Ruyer, O
Feissel, M
Engquist, A
Strom, J
Bonde, J
Desmonts, JM
Montravers, P
Lagoueyte, JF
Tenaillon, A
Lawkoune, JM
Boiteau, R
Cardinaud, JP
Benissan, G
Chastre, J
Gibert, C
Daoudal, P
Delacourt, M
Fouet, P
Hilpert, F
Smithies, M
Bihari, D
Perrotin, D
Dequin, PF
[J]. CRITICAL CARE MEDICINE, 1998, 26 (12) : 1963 - 1971

← 1 2 3 →